It is known that B cells can activate CD8+ T cells though IgA-FcR signaling, however it remains to be determined how B cell MHC I expression changes during NASH and how this impacts CD8+ T cell activation (33). This evidence concerns the gene CD79A and metabolic dysfunction-associated steatohepatitis.